Legal cannabis is already the fastest growing industry in North America. North American cannabis sales jumped 30% in 2017, a repeat of 2016’s stunning gain. While that’s impressive on its own, the pace of growth is about to accelerate due to a huge catalyst directly on the horizon. Canada has announced plans to legalize recreational cannabis by July 2018. That would make Canada the first developed country in the world to legalize both medical and recreational cannabis. It’s also set to unleash a multi-billion dollar industry. Cannabis sales are expected to be between $5 and $7… Read More
Legal cannabis is already the fastest growing industry in North America. North American cannabis sales jumped 30% in 2017, a repeat of 2016’s stunning gain. While that’s impressive on its own, the pace of growth is about to accelerate due to a huge catalyst directly on the horizon. Canada has announced plans to legalize recreational cannabis by July 2018. That would make Canada the first developed country in the world to legalize both medical and recreational cannabis. It’s also set to unleash a multi-billion dollar industry. Cannabis sales are expected to be between $5 and $7 billion in the first 12 months after legalization. That would be between a 400 percent and 600 percent increase from Canada’s 2017 numbers. If you want to learn how you can potentially profit from this cannabis revolution, let me tell you about one of the most promising companies in Canada’s high-growth cannabis market. #-ad_banner-#Aphria (TSE: APH) is an early leader in Canada’s high-growth cannabis industry. With a market cap of $2.4 billion, Aphria is the second-largest cannabis company in Canada behind Canopy Growth Corp’s (TSE: WEED) $6.6 billion. Shares of Aphria are traded on the Toronto Stock Exchange under the… Read More